These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1819041)
41. Tetrapyrrole biosynthesis: N-methyl-N'-nitrosoguanidine-induced mutants of Propionibacterium shermanii. Georgopapadakou RH; Petrillo J; Scott AI; Low B Genet Res; 1976 Aug; 28(1):93-100. PubMed ID: 795726 [No Abstract] [Full Text] [Related]
42. Antimutagenicity of the porphyrins and non-enzyme porphyrin-containing proteins. Odin AP Mutat Res; 1997 Aug; 387(1):55-68. PubMed ID: 9254893 [No Abstract] [Full Text] [Related]
44. Antimutagenicity of Lactic Acid Bacteria from "Idly" Against Food-Related Mutagens. Thyagaraja N; Hosono A J Food Prot; 1993 Dec; 56(12):1061-1066. PubMed ID: 31113116 [TBL] [Abstract][Full Text] [Related]
45. Purification and properties of erythritol kinase from Propionibacterium pentosaceum. HOLTEN D; FROMM HJ J Biol Chem; 1961 Oct; 236():2581-4. PubMed ID: 13908588 [No Abstract] [Full Text] [Related]
46. Use of sodium azide in isolation of gram-positive cocci. SCHWARTING VM Am J Clin Pathol; 1946 Jul; 10():123-5. PubMed ID: 20995627 [No Abstract] [Full Text] [Related]
47. Antimutagenicity in cultured mammalian cells. Kuroda Y; Jain AK; Tezuka H; Kada T Mutat Res; 1992 Jun; 267(2):201-9. PubMed ID: 1376422 [No Abstract] [Full Text] [Related]
48. Inhibitory Effect of Autoclaving Whey-Based Medium on Propionic Acid Production by Propionibacterium shermanii. Anderson TM; Bodie EA; Goodman N; Schwartz RD Appl Environ Microbiol; 1986 Feb; 51(2):427-8. PubMed ID: 16346998 [TBL] [Abstract][Full Text] [Related]
49. Mechanism of Propionic Acid Formation by Propionibacterium pentosaceum. Delwiche EA J Bacteriol; 1948 Dec; 56(6):811-20. PubMed ID: 16561634 [No Abstract] [Full Text] [Related]
50. More on interference of sodium azide with measurement of total and conjugated bilirubin in serum. Khayam-Bashi H Clin Chem; 1979 Mar; 25(3):489. PubMed ID: 262193 [No Abstract] [Full Text] [Related]
51. Sodium azide poisoning in five laboratory technicians. Edmonds OP; Bourne MS Br J Ind Med; 1982 Aug; 39(3):308-9. PubMed ID: 7093160 [TBL] [Abstract][Full Text] [Related]
52. Assessment of antimutagenicity and anticarcinogenicity--end-points and systems. Mutat Res; 1992 Jun; 267(2):153-295. PubMed ID: 1376416 [No Abstract] [Full Text] [Related]
53. Fatal azide-induced cardiomyopathy presenting as acute myocardial infarction. Judge KW; Ward NE Am J Cardiol; 1989 Oct; 64(12):830-1. PubMed ID: 2801544 [No Abstract] [Full Text] [Related]
54. Explosive hazard of blood diluents containing sodium azide. LaLuna FJ; Wright RE; Heim WJ N Engl J Med; 1979 Aug; 301(7):382-3. PubMed ID: 460328 [No Abstract] [Full Text] [Related]
55. Is sodium azide preservative a carcinogen? Liu TZ Clin Chem; 1979 Aug; 25(8):1514-5. PubMed ID: 455702 [No Abstract] [Full Text] [Related]
56. The role of phosphate in the metabolism of Propionibacterium pentosaceum. BARKER HA; LIPMANN F J Biol Chem; 1949 May; 179(1):247-57. PubMed ID: 18125968 [No Abstract] [Full Text] [Related]
57. [Commercial antazides and acid neutralization]. TEPE HJ Dtsch Med Wochenschr; 1955 Jun; 80(23):891-2. PubMed ID: 14391028 [No Abstract] [Full Text] [Related]
58. Evidence for the antimutagenicity and the mutagenicity of selenium. Shamberger RJ Biol Trace Elem Res; 1980 Mar; 2(1):81-8. PubMed ID: 24272855 [TBL] [Abstract][Full Text] [Related]
59. The fixation of CO(2) by cell suspensions of Propionibacterium pentosaceum. Wood HG; Werkman CH Biochem J; 1940 Jan; 34(1):7-14. PubMed ID: 16747140 [No Abstract] [Full Text] [Related]
60. Fluoride sensitivity of Propionibacterium pentosaceum as a function of growth conditions. Wiggert WP; Werkman CH Biochem J; 1939 Jul; 33(7):1061-9. PubMed ID: 16747004 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]